Pantheon Investment Group’s Edwards Lifesciences EW Stock Holding History

Pantheon Investment Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$2.52M	Buy	19,533 +637	+3%	+$74.3K	1.98%	10
2021 Q3	$2.14M	Sell	18,896 -917	-5%	-$105K	1.84%	12
2021 Q2	$2.05M	Sell	19,813 -853	-4%	-$80.4K	1.72%	16
2021 Q1	$1.73M	Buy	20,666 +2,758	+15%	+$233K	1.66%	21
2020 Q4	$1.63M	Sell	17,908 -512	-3%	-$42.5K	1.78%	17
2020 Q3	$1.47M	Sell	18,420 -1,068	-5%	-$83.3K	1.75%	18
2020 Q2	$1.35M	Buy	19,488 +741	+4%	+$52.7K	1.69%	20
2020 Q1	$1.18M	Buy	18,747 +7,944	+74%	+$573K	1.77%	21
2019 Q4	$839K	Buy	+10,803	New	+$844K	0.79%	41

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pantheon Investment Group's EW Position: Q4 2021 in Review

Pantheon Investment Group increased its Edwards Lifesciences (EW) stake by 3.4% in Q4 2021, buying an estimated $74.3K and bringing the position to 19,533 shares worth $2.52M. The position accounts for 1.98% of the portfolio, ranked #10.

Pantheon Investment Group first reported a position in EW in Q4 2019 and has held it in 9 quarters since. 1,320 funds tracked by Wall St. Rank hold EW as of Q4 2021.

Pantheon Investment Group held 19,533 shares of Edwards Lifesciences worth $2.52M as of Q4 2021.
Pantheon Investment Group bought 637 Edwards Lifesciences shares in Q4 2021, an estimated $74.3K.
Edwards Lifesciences made up 1.98% of Pantheon Investment Group's portfolio in Q4 2021, its #10 holding.
Pantheon Investment Group first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 9 quarters since.
1,320 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2021.

Based on Pantheon Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.